From: Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review
Reference | Study Design | Sample Population | Intervention | Control | Length of Treatment | Outcomes | Direction of Evidence | Reported Adverse Events |
---|---|---|---|---|---|---|---|---|
Bourin (1997) [34] | Randomized; Double-blind; Parallel Group | 182 outpatients with adjustment disorder with anxious mood | Euphytose1; 2 tablets, 3 times a day | Placebo tablets | 28 days | Significant reduction in HAMA scores (from D7 to D28) in favour of Euphytose treatment | + | No serious AEs. Dry mouth Headache Constipation Drowsiness |
Akhondzadeh (2001) [32] | Randomized; Double-blind; Parallel group | 36 outpatients with DSM-IV for GAD for at least 6 months | 45 drops/day of Passiflora extract plus placebo tablet | Oxazepam 30 mg/day plus placebo drops | 4 weeks | Decrease in HAMA for both treatments2; overall no significant difference in efficacy between treatments | + | Higher impairment of job performance in oxazepam group; overall no significant difference in total side effects3 |
Movafegh (2008) [33] | Randomized; Double-blind; Parallel Group | 60 patients undergoing inguinal herniorrhaphy | Oral Passiflora incarnata (500 mg, Passipyâ„¢ IranDarouk) | Placebo | Given as pre-medication 90 minutes before surgery | NRS anxiety scores were significantly lower in the passiflora group | + | Not reported |